We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




American Gut Project Reports Microbiome Results

By LabMedica International staff writers
Posted on 31 May 2018
Although much work has linked the human microbiome to specific phenotypes and lifestyle variables, data from different projects have been challenging to integrate and the extent of microbial and molecular diversity in human stool remains unknown.

Two projects have been launched, the American Gut Project (AGP) in November 2012 as a collaboration between the Earth Microbiome Project (EMP) and the Human Food Project (HFP) to discover the kinds of microbes and microbiomes “in the wild” via a self-selected citizen-scientist cohort.

A large team of international scientists collaborating with the University of California, San Diego (La Jolla, CA, USA) received stool samples from individuals in the USA, UK, and dozens of other countries. More...
Participants completed voluntary surveys related to their diet, lifestyle, health status, and disease history, including nearly 1,800 individuals who took part in a picture-based food frequency questionnaire.

The team used MiSeq or HiSeq instruments to sequence 16S rRNA V4 regions in the samples to characterize their microbial composition. They also cultured a subset of samples, which were subjected to shotgun metagenomic sequencing with the Illumina HiSeq 2500 and metabolite profiling by high-performance liquid chromatography and mass spectrometry (HPLC-MS).

In addition to pronounced overall microbial diversity, the team noted that differences found between one gut microbiome and the next were sometimes on par with those described in distinct environments for the EMP. The team was also able to profile gut microbiome composition in individuals with or without psychiatric conditions such as depression, schizophrenia, bipolar disorder, or post-traumatic stress disorder, uncovering gut microbiomes that clustered apart from those of 125 unaffected individuals.

When it came to diet, the scientists detected ties between the number of plant types individuals consumed and their gut microbial diversity, regardless of whether their overall diet was vegan or vegetarian. Likewise, those who reported eating plant-rich fare (30 types of plants per week or more) were less apt to carry bugs with antibiotic resistance genes compared to those who consumed 10 types of plants per week or fewer. Perhaps more unexpectedly, the team's comparison of 139 recent users of antibiotics and 117 individuals who were antibiotic-free for a year or more revealed rising metabolomic diversity following antibiotic use, despite falling microbial diversity.

Daniel McDonald, PhD, a scientific director for American Gut and the lead author of the study, said, “We observed a much greater microbial diversity than previous smaller studies found, and that suggests that if we look at more populations, we'll see more diversity, which is important for defining the boundaries of the human microbiome.” The study was published on May 15, 2018, in the journal mSystems.

Related Links:
University of California, San Diego


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated PCR Setup
ESTREAM
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.